In light of the Life Sciences Industrial Strategy’s ambitious goals, Dr Michael Hopkins (SPRU – Science Policy Research Unit) sets out to examine the strengths and weaknesses of the UK’s medical innovation ecosystem in a new policy brief. Drawing on…